Physician profile
Jonathan D Mock
NPI 1578640884
$7,212.19
in general payments reported to CMS, 2019-2025
32 companies · $1,674 in 2025
The $1,674 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $852 · 2020: $1,120 · 2021: $653 · 2022: $737 · 2023: $768 · 2024: $1,408 · 2025: $1,674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,850.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,341.21 | 2019-2024 | Xarelto |
| Abiomed | $671.70 | 2019-2025 | Impella |
| Medtronic, INC. | $603.14 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Linq II |
| Inari Medical, INC. | $594.75 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bard Peripheral Vascular, INC. | $540.19 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $438.33 | 2023-2025 | |
| Stryker Corporation | $410.62 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $246.70 | 2023-2025 | Lifevest |
| Zimmer Biomet Holdings, INC. | $244.79 | 2020-2022 | |
| Shockwave Medical, INC | $237.44 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abbott Laboratories | $194.93 | 2019-2025 | Dragonfly Opstar, Optis, Pressurewire |
| Medtronic Vascular, INC. | $187.88 | 2019-2020 | |
| Pfizer INC. | $182.13 | 2022-2025 | |
| Amarin Pharma, INC. | $161.23 | 2019-2020 | |
| Boston Scientific Corporation | $160.38 | 2019-2025 | General - Embolics, Embold Fibered, Icefx Cryoablation System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $139.01 | 2019-2025 | Repatha, Repatha |
| Bolton Medical INC | $128.99 | 2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Edwards Lifesciences Corporation | $121.80 | 2019-2025 | Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.07 | 2021-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $94.19 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $73.91 | 2022-2025 | Eliquis |
| Cook Medical LLC | $50.54 | 2019 | |
| Lantheus Medical Imaging, INC. | $49.02 | 2022-2025 | |
| Impulse Dynamics (USA) INC. | $47.31 | 2023-2024 | Optimizer, Optimizer |
| Novo Nordisk INC | $44.47 | 2024 | Ozempic, Rybelsus |
| Teleflex LLC | $29.21 | 2024-2025 | Turnpike, Guideliner |
| Roche Diagnostics Corporation | $27.43 | 2019 | |
| Cardiovascular Systems INC. | $23.78 | 2020 | |
| Chiesi USA, INC. | $17.88 | 2020 | |
| Merck Sharp & Dohme LLC | $17.30 | 2023 | Verquvo |
| Siemens Medical Solutions USA, INC. | $15.86 | 2025 | Artis Q Floor |
| Tactile Systems Technology INC | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Mock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.